Neuroprotective Effects of Activin A against Cerebral Ischemia/Reperfusion Injury in Mice by Enhancing Nrf2 Expression to Attenuate Neuronal Ferroptosis
ACS Chemical Neuroscience · 2023
DOI: 10.1021/acschemneuro.3c00374 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Fengzhi Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Erdao District, Changchun 130033, China. Hauptthemen laut MEDLINE: Neuroprotective Agents, Ferroptosis, Brain Ischemia, Reperfusion Injury. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Department of Science and Technology of Jilin Province, Youth Science and Technology Innovation Project of Shenyang.
Abstract (Originalsprache)
Activin A (Act A) is a member of the transforming growth factor-β (TGF-β) superfamily and can protect against ischemic cerebral injury. Ferroptosis, a newly discovered type of programmed cell death, contributes to the pathogenesis of cerebral ischemia-reperfusion injury (CIRI). However, little is known on whether Act A can modulate neuronal ferroptosis to protect against CIRI in a mouse model of middle cerebral artery occlusion (MCAO) and an HT22 cell model of oxygen-glucose deprivation/reoxygenation (OGD/R). The results indicated that Act A treatment relieved CIRI by improving neurological deficits and reducing the infarct volume in mice. MCAO stimulated iron accumulation and malondialdehyde formation and upregulated ACSL4 expression but downregulated GPX4 expression, a hallmark of ferroptosis in the brain of mice. Treatment with Act A significantly mitigated MCAO-triggered ferroptosis in the brain of mice. Furthermore, Act A treatment enhanced the MCAO-upregulated nuclear factor erythroid-2-related factor 2 (Nrf2) expression in the brains of mice. Similar results were observed in HT22 cells following OGD/R and pretreatment with Act A. The neuronal protective effect of Act A in HT22 cells was attenuated by treatment with ML385, an Nrf2 inhibitor. To conclude, Act A attenuated CIRI by enhancing Nrf2 expression and inhibiting neuronal ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Erdao District, Changchun 130033, China.
- Department of Neurology, People's Hospital of China Medical University, People's Hospital of Liaoning Province, 33 Wenyi Road, Shenhe District, Shenyang 110016, China.
ORCID-Profile: Zhongxin Xu
Förderung
- Department of Science and Technology of Jilin Province
- Youth Science and Technology Innovation Project of Shenyang
Zitieren
APA
Wang, F., Ma, M., Yang, J., Shi, X., Wang, J., & Xu, Z. (2023). Neuroprotective Effects of Activin A against Cerebral Ischemia/Reperfusion Injury in Mice by Enhancing Nrf2 Expression to Attenuate Neuronal Ferroptosis. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00374
Vancouver
Wang F, Ma M, Yang J, Shi X, Wang J, Xu Z. Neuroprotective Effects of Activin A against Cerebral Ischemia/Reperfusion Injury in Mice by Enhancing Nrf2 Expression to Attenuate Neuronal Ferroptosis. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00374
BibTeX
@article{Wang2023,
author = {Wang, Fengzhi and Ma, Ming and Yang, Jiahui and Shi, Xiaohua and Wang, Jiaoqi and Xu, Zhongxin},
title = {Neuroprotective Effects of Activin A against Cerebral Ischemia/Reperfusion Injury in Mice by Enhancing Nrf2 Expression to Attenuate Neuronal Ferroptosis},
journal = {ACS Chemical Neuroscience},
year = {2023},
doi = {10.1021/acschemneuro.3c00374}
}
EUVIMED